USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
AI-enabled Technologies are Transforming the Pharmaceutical Supply Chain Network
21-Jan-2025
Global
Technology Research
DB13-01-00-00-00
HC_2025_1261
This study aims to review emerging, transformative technology solutions that redesign pharmaceutical supply chain processes and introduce increased resilience, transparency, and responsiveness into the model.
The study answers the following questions:
What are some new challenges big pharma's supply chains must address today? How can emerging technologies help lead the way in transparency and resilience?
How do different technological solutions allow connectivity and communication among important pharmaceutical supply chain stakeholders?
Given the recent global economic shocks, what new technology application strategies can pharmaceutical companies deploy to make their supply chains more responsive and efficient?
How can managers implement supplier synergies with technology companies and pharmaceutical companies benefit from formulating a more solid and integrated model for the pharmaceutical industry's supply chain?
How do the funding, technical readiness, and strategic collaborations of key companies in this field influence the development and potential success of the pharmaceutical supply chain?
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Technologies Enabling Resilient Pharmaceutical Supply Chains
Growth Opportunities Fuel the Growth Pipeline Engine™
Research Methodology
Scope of Analysis
Introduction
Segmentation
Growth Drivers
Growth Restraints
Manufacturers to Wholesalers
Wholesalers to Pharmacies
Pharmacies to Patients
Key Pharmaceutical Supply Chain Participants
Key Pharmaceutical Supply Chain Participants (continued)
Key Pharmaceutical Supply Chain Participants (continued)
Funding Analysis
Key Partnerships and Acquisitions, 2021–2024
Manufacturers to Wholesalers—Outlook
Wholesalers to Pharmacies—Outlook
Pharmacies to Patients—Outlook
Growth Opportunity 1: IoT-enabled Tracking and Monitoring
Growth Opportunity 1: IoT-enabled Tracking and Monitoring (continued)
Growth Opportunity 2: Blockchain for Enhanced Transparency and Traceability
Growth Opportunity 2: Blockchain for Enhanced Transparency and Traceability (continued)
Growth Opportunity 3: Data Analytics and AI-driven Decision-making
Growth Opportunity 3: Data Analytics and AI-driven Decision-making (continued)
Benefits and Impacts of Growth Opportunities
Next Steps
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Pharmaceuticals and Biotech research
16 Jan 2025 | Global | Technology Research
Advanced Therapeutics for the Infectious Disease Management Market, Global, 2024-2029
Antimicrobial resistance (AMR), the emergence of new pathogens, and breakthroughs in biotechnology have significantly transformed the global landscape of infectious diseases. This Frost & Sullivan report focuses on advanced therapeutics for the infectious disease management industry. It offers an an...
28 Oct 2024 | Global | Frost Radar
Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2024
With an inclination toward patient-centric care delivery, the pharma industry follows a robust, step-by-step approach to market commercialization, with a clear understanding of the market stakeholders, segments, and post-launch forecasts to create seamless go-to-market strategies, develop a positive...
10 Sep 2024 | Global | Market Research
Pharmaceutical Commercialization Solutions and Services Industry, Global, 2024 2029
With the growing preference for a patient-centric care delivery approach, the pharma industry follows a robust step-by-step approach towards market commercialization, with a clear understanding of the market stakeholders, segments, as well as post-launch forecasts to create seamless go-to-market str...
10 Sep 2024 | Global | Technology Research
Technology Advances in Modular and Automated Platforms for Pharmaceutical Manufacturing
This study examines technology advances in modular and automated platforms for non-biologics manufacturing in the pharmaceutical sector. There is a growing demand for automated and modular technologies that ensure regulatory compliance, increase productivity, reduce waste, and meet emerging therapeu...
09 Sep 2024 | Global | Technology Research
AI-based Drug Repurposing Market, Growth Opportunities, Global, 2024-2029
This study analyzes the emergence of AI-based drug repurposing and examines the factors driving and hindering adoption. The limitation of traditional drug discovery has led to the growing interest in AI -based drug repurposing, which offers numerous advantages in terms of time, speed, and cost. AI-b...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Technology Research |
|---|---|
| Author | Pooja Suresh |
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | Pharma Supply Chains |
| Keyword 2 | Resilience Technologies |
| Keyword 3 | Healthcare Challenges |
| Podcast | No |
| WIP Number | DB13-01-00-00-00 |
Technologies Enabling Resilient Pharmaceutical Supply Chains
$4,950.00
Special Price $4,207.50 save 15 %